In collaboration with Beaumont Hospital, investigations were conducted of clot fragments retrieved in individual stroke cases and the number of attempts required to retrieve the clot. The knowledge generated from this ‘per-pass’ study of acute ischemic stroke has generated more informative data regarding thrombus composition, recanalisation outcomes and a possible approach to analysing thrombi in the future.
Additionally, Dr Duffy characterised a number of CERENOVUS’s clot analogues that replicate acute ischemic stroke occlusions in vitro. Among other applications, these clot analogues have been used for design verification testing of the company’s devices. Ultimately this IRC co-funded project with CERENOVUS provided greater knowledge on the relationship between thrombus composition and endovascular therapies for acute ischemic stroke.
Siesta Sofas